Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy

被引：0
|
作者：
Taiki Hakozaki
Yukio Hosomi
Akihiro Shimizu
Rui Kitadai
Kie Mirokuji
Yusuke Okuma
机构：
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Thoracic Oncology and Respiratory Medicine
[2] National Cancer Center Hospital,Department of Thoracic Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Polypharmacy; Non-small cell lung cancer; Overall survival; Geriatric oncology; Comorbidity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2659 / 2668
页数：9
相关论文
共 50 条
  • [1] Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy
    Hakozaki, Taiki
    Hosomi, Yukio
    Shimizu, Akihiro
    Kitadai, Rui
    Mirokuji, Kie
    Okuma, Yusuke
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2659 - 2668
  • [2] Anti-PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy
    Valecha, Gautam Kishore
    Vennepureddy, Adarsh
    Ibrahim, Uroosa
    Safa, Firas
    Samra, Bachar
    Atallah, Jean Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (01) : 47 - 59
  • [3] Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study
    Morikawa, Noboru
    Naito, Tateaki
    Morita, Meiko
    Sekikawa, Motoki
    Doshita, Kosei
    Yabe, Michitoshi
    Kodama, Hiroaki
    Miura, Keita
    Iida, Yuko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Ko, Ryo
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (07)
  • [4] Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
    Nishioka, Naoya
    Uchino, Junji
    Hirai, Soichi
    Katayama, Yuki
    Yoshimura, Akihiro
    Okura, Naoko
    Tanimura, Keiko
    Harita, Sachi
    Imabayashi, Tatsuya
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (04)
  • [5] Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice
    Califano, Raffaele
    Lal, Rohit
    Lewanski, Conrad
    Nicolson, Marianne C.
    Ottensmeier, Christian H.
    Popat, Sanjay
    Hodgson, Matthew
    Postmus, Pieter E.
    FUTURE ONCOLOGY, 2018, 14 (23) : 2415 - 2431
  • [6] PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade
    Yoshida, Hironori
    Nomizo, Takashi
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Funazo, Tomoko
    Yasuda, Yuto
    Ajimizu, Hitomi
    Yamazoe, Masatoshi
    Kuninaga, Kiyomitsu
    Ogimoto, Tatsuya
    Hosoya, Kazutaka
    Itotani, Ryo
    Sakamori, Yuichi
    Kim, Young Hak
    Hirai, Toyohiro
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 317 - 325
  • [7] Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small-cell lung cancer: a network meta-analysis
    Chen, Jiarui
    Liu, Xingyu
    Zhang, Junhong
    Huang, Zhao
    Zeng, Wei
    Hu, Jing
    Chen, Gang
    Gong, Yan
    Liu, Yu
    Xie, Conghua
    FUTURE ONCOLOGY, 2022, 18 (13) : 1651 - 1664
  • [8] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer
    Zhang, Shuling
    Bai, Xueli
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [9] Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
    Su, Chaoyue
    Wang, Hui
    Liu, Yunru
    Guo, Qiaoru
    Zhang, Lingling
    Li, Jiajun
    Zhou, Wenmin
    Yan, Yanyan
    Zhou, Xinke
    Zhang, Jianye
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer
    Woodford, Rachel
    Zhou, Deborah
    Lord, Sarah J.
    Marschner, Ian
    Cooper, Wendy A.
    Lewis, Craig R.
    John, Thomas
    Yang, James Chih-Hsin
    Lee, Chee Khoon
    FUTURE ONCOLOGY, 2022, 18 (14) : 1793 - 1799
12345